External Data Management Intern
Genmab
Summary
The External Data Management (DMx) Intern plays a key role in supporting Genmab's drug development programs through a 10-week summer internship focused on gaining practical experience in developing tools, metrics, and process improvements that support leadership's oversight of clinical trial external data. In this role, the intern will gain exposure to data management reference systems, documentation practices, operational metrics, and financial reconciliation processes.
Job description
Job Overview
The External Data Management (DMx) Intern plays a key role in supporting Genmab's drug development programs through a 10-week summer internship focused on gaining practical experience in developing tools, metrics, and process improvements that support leadership's oversight of clinical trial external data. In this role, the intern will gain exposure to data management reference systems, documentation practices, operational metrics, and financial reconciliation processes.
Working closely with cross-functional partners, the intern will contribute to real-world portfolio and process-improvement initiatives and will take ownership of end-to-end assignments that demonstrate measurable impact on Genmab's development pipeline. This internship offers a structured learning environment, dedicated mentorship, and the opportunity to apply analytical and problem-solving skills to meaningful challenges in clinical data management.
What You'll Do
- Assist with preparing, presenting, and evaluating metrics for external data vendors to identify possible process gaps and quality improvement opportunities.
- Assess vendor contracts to ensure that data transfers and related activities are accurately accounted for and invoiced appropriately.
- Support quality oversight of DM CROs' external data reconciliation by compiling metrics on current processes.
- Support development and improvement of DMx SharePoint site, vendor reference documentation, and shared folder areas.
Required Qualifications, Capabilities And Skills
- Enrollment in a Bachelor's, Master's, or PhD program in Data Science, Clinical Trial Management, or a related field.
- Strong organization, analytical, and problem-solving skills.
- Proactive, accountable, with a willingness to learn.
- Excellent written and verbal communication skills.
- Ability to work independently and as part of a collaborative team.
- High attention to detail and commitment to quality work.
- Genuine interest in clinical research and drug development.
Preferred Qualifications, Capabilities And Skills
- Demonstrates initiative, a proactive attitude, and eagerness to learn in a fast-paced environment.
- Effectively communicates and collaborates with team members, mentors, and stakeholders.
- Maintains attention to detail and quality in all deliverables while managing multiple tasks.
- Leverages feedback to refine technical and professional skills.
- Familiarity with data presentation and systems is helpful; Excel and SharePoint experience is a plus.
General Intern Information – Date/Location/Schedule
Internships will take place over 10 weeks from June – August 2027. This role will be based in Princeton, NJ and operate on a required hybrid schedule – 3 days in the office and 2 days remote per week. This role is not eligible for work visa sponsorship at the time of the application or in the future.
Requirements
- Enrollment in a Bachelor's, Master's, or PhD program in Data Science, Clinical Trial Management, or a related field
- Strong organization, analytical, and problem-solving skills
- Proactive, accountable, with a willingness to learn
- Excellent written and verbal communication skills
- Ability to work independently and as part of a collaborative team
- High attention to detail and commitment to quality work
- Genuine interest in clinical research and drug development
Company overview
Genmab is a leading international biotechnology company headquartered in Copenhagen, Denmark, specializing in the development and commercialization of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has established itself as a pioneer in antibody technology with its proprietary DuoBody, HexaBody, and DuoHexaBody platforms. Genmab's innovative approach focuses on creating next-generation antibody-based therapies that target specific cancer cells while minimizing damage to healthy tissues. The company has several marketed products including DARZALEX (daratumumab) for multiple myeloma, which has become a cornerstone treatment in hematological malignancies. Genmab's pipeline includes numerous clinical-stage candidates targeting various cancers, leveraging its expertise in antibody engineering to develop novel immunotherapies. The company collaborates with major pharmaceutical partners worldwide and maintains a strong commitment to advancing cancer treatment through cutting-edge science and patient-focused innovation.